CA
CalciMedica, Inc. (CALC)
NASDAQ·Healthcare·Biotechnology
$1.35
+3.85%
Mkt Cap $9.29M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$266.00
Range $14.00 – $392.00
Implied Upside
+19603.7%
Consensus $266.00 vs current $1.35
NASDAQ·Healthcare·Biotechnology
$1.35
+3.85%
Mkt Cap $9.29M
No recent rating data.
Price Target (3 analysts)
$266.00
Range $14.00 – $392.00
+19603.7%
Consensus $266.00 vs current $1.35